Thermo Fisher Scientific (TMO)
582.38
0.00 (0.00%)
Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows
The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide.
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 3, 2025
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 31, 2025
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
TMO earnings call for the period ending December 31, 2024.
Via The Motley Fool · January 30, 2025
![](https://news-assets.stockstory.org/cover-images/thermo-fisher-scientific-cover-image-5c35c1b9d3db_2024-12-17-134314_iegm.jpeg)
Life sciences company Thermo Fisher (NYSETMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above analysts’ consensus estimates.
Via StockStory · January 30, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.
Via Chartmill · January 30, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 21, 2025
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 17, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · January 30, 2025
![](https://www.investors.com/wp-content/uploads/2019/03/stock-Thermo-Fisher-06-company.jpg)
Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts.
Via Investor's Business Daily · January 30, 2025
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.
Via Chartmill · January 30, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/30/Indianapolis---Circa-March-2023-Thermo-F.jpeg?width=1200&height=800&fit=crop)
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.
Via Benzinga · January 30, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 29, 2024
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 28, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/26/Chatbot-Conversation-Ai-Artificial-Intel.jpeg?width=1200&height=800&fit=crop)
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
Via Benzinga · January 26, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/24/Stethoscope-Laying-On-Medicine-White-Pil.jpeg?width=1200&height=800&fit=crop)
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.
Via Benzinga · January 24, 2025
![](https://www.marketbeat.com/logos/articles/med_20250123122551_cash-flow-focus-thermo-fisher-energy-transfer-and.jpg)
Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.
Via MarketBeat · January 24, 2025
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 1, 2025
![](https://cdn.benzinga.com/files/images/story/2024/12/23/Analysts-Pick-4-Stocks-Poised-for-Growth.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 23, 2024
![](https://public.newsdirect.com/750745204/A35c4UUD.png)
Via News Direct · December 20, 2024
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 13, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/03/Man-at-computer--Business-Finance-Data-A.jpeg?width=1200&height=800&fit=crop)
Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results.
Via Benzinga · December 3, 2024
![](https://public.newsdirect.com/351740583/oFcVguDs.png)
Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test
Via News Direct · November 22, 2024